Citation: Wj. Mckenna et al., Management strategies in hypertrophic cardiomyopathy: influence of age andmorphology, EUR H J SUP, 3(L), 2001, pp. L10-L14
Authors:
Caforio, ALP
Goldman, JH
Baig, MK
Mahon, NJ
Haven, AJ
Souberbielle, BE
Holt, DW
Dalgleish, AG
McKenna, WJ
Citation: Alp. Caforio et al., Elevated serum levels of soluble interleukin-2 receptor, neopterin and beta-2-microglobulin in idiopathic dilated cardiomyopathy: relation to diseaseseverity and autoimmune pathogenesis, EUR J HE FA, 3(2), 2001, pp. 155-163
Authors:
Priori, SG
Aliot, E
Blomstrom-Lundqvist, C
Bossaert, L
Breithardt, G
Brugada, P
Camm, AJ
Cappato, R
Cobbe, SM
Di Mario, C
Maron, BJ
McKenna, WJ
Pedersen, AK
Ravens, U
Schwartz, PJ
Trusz-Gluza, M
Vardas, P
Wellens, HJJ
Zipes, DP
Citation: Sg. Priori et al., Task force on sudden cardiac death of the European Society of Cardiology, EUR HEART J, 22(16), 2001, pp. 1374-1450
Authors:
Khogali, SS
Mayosi, BM
Beattie, JM
McKenna, WJ
Watkins, H
Poulton, J
Citation: Ss. Khogali et al., A common mitochondrial DNA variant associated with susceptibility to dilated cardiomyopathy in two different populations, LANCET, 357(9264), 2001, pp. 1265-1267
Citation: Pm. Elliott et al., Relation between severity of left-ventricular hypertrophy and prognosis inpatients with hypertrophic cardiomyopathy, LANCET, 357(9254), 2001, pp. 420-424
Authors:
MacFarlane, CE
Brown, DC
Johnston, LB
Patton, MA
Dunger, DB
Savage, MO
McKenna, WJ
Kelnar, CJH
Citation: Ce. Macfarlane et al., Growth hormone therapy and growth in children with Noonan's syndrome: Results of 3 years' follow-up, J CLIN END, 86(5), 2001, pp. 1953-1956
Authors:
Varnava, AM
Elliott, PM
Baboonian, C
Davison, F
Davies, MJ
McKenna, WJ
Citation: Am. Varnava et al., Hypertrophic cardiomyopathy - Histopathological features of sudden death in cardiac troponin T disease, CIRCULATION, 104(12), 2001, pp. 1380-1384
Authors:
Varnava, AM
Elliott, PM
Sharma, S
McKenna, WJ
Davies, MJ
Citation: Am. Varnava et al., Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease, HEART, 84(5), 2000, pp. 476-482
Authors:
Steptoe, A
Mohabir, A
Mahon, NG
McKenna, WJ
Citation: A. Steptoe et al., Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy, HEART, 83(6), 2000, pp. 645-650
Authors:
Mahon, NG
Sharma, S
Elliott, PM
Baig, MK
Norman, MW
Barbeyto, S
McKenna, WJ
Citation: Ng. Mahon et al., Abnormal cardiopulmonary exercise variables in asymptomatic relatives of patients with dilated cardiomyopathy who have left ventricular enlargement, HEART, 83(5), 2000, pp. 511-517
Authors:
Corrado, D
Fontaine, G
Marcus, FI
McKenna, WJ
Nava, A
Thiene, G
Wichter, T
Citation: D. Corrado et al., Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Need for an international registry (Reprinted from Circulation Online, March 21, pg E101, 2000), J CARD ELEC, 11(7), 2000, pp. 827-832
Authors:
Elliott, PM
Poloniecki, J
Dickie, S
Sharma, S
Monserrat, L
Varnava, A
Mahon, NG
McKenna, WJ
Citation: Pm. Elliott et al., Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients, J AM COL C, 36(7), 2000, pp. 2212-2218
Authors:
Sharma, S
Elliott, PM
Whyte, G
Mahon, N
Virdee, MS
Mist, B
McKenna, WJ
Citation: S. Sharma et al., Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes, J AM COL C, 36(3), 2000, pp. 864-870
Citation: L. Monserrat et Wj. Mckenna, Importance of syncope and electrical stimulation to predict sudden death in hypertrophic cardiomyopathy - Response, REV ESP CAR, 53(12), 2000, pp. 1673-1673
Citation: Wj. Mckenna et Lm. Iglesias, Identification and treatment of patients with hypertrophhic cardiomyopathyat risk of sudden death, REV ESP CAR, 53(1), 2000, pp. 123-130